- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Biochemistry Research International
Volume 2012 (2012), Article ID 453838, 8 pages
“Dead Cells Talking”: The Silent Form of Cell Death Is Not so Quiet
1Department of Natural Sciences, Bonn-Rhein-Sieg University of Applied Sciences, 53359 Rheinbach, Germany
2Department of Pharmacology and Therapeutics, NUI Galway, Galway, Ireland
Received 3 May 2012; Accepted 3 July 2012
Academic Editor: Eun-Kyoung Yim Breuer
Copyright © 2012 Richard Jäger and Howard O. Fearnhead. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- G. Melino, R. A. Knight, and J. C. Ameisen, “The Siren’s song: this death that makes life live,” in Cell Death, G. Melino and D. Vaux, Eds., John Wiley & Sons, 2010.
- R. C. Taylor, S. P. Cullen, and S. J. Martin, “Apoptosis: controlled demolition at the cellular level,” Nature Reviews Molecular Cell Biology, vol. 9, no. 3, pp. 231–241, 2008.
- Y. Fan and A. Bergmann, “Distinct mechanisms of apoptosis-induced compensatory proliferation in proliferating and differentiating tissues in the Drosophila eye,” Developmental Cell, vol. 14, no. 3, pp. 399–410, 2008.
- A. S. Tseng, D. S. Adams, D. Qiu, P. Koustubhan, and M. Levin, “Apoptosis is required during early stages of tail regeneration in Xenopus laevis,” Developmental Biology, vol. 301, no. 1, pp. 62–69, 2007.
- J. S. Hwang, C. Kobayashi, K. Agata, K. Ikeo, and T. Gojobori, “Detection of apoptosis during planarian regeneration by the expression of apoptosis-related genes and TUNEL assay,” Gene, vol. 333, pp. 15–25, 2004.
- S. Chera, L. Ghila, K. Dobretz et al., “Apoptotic cells provide an unexpected source of Wnt3 signaling to drive hydra head regeneration,” Developmental Cell, vol. 17, no. 2, pp. 279–289, 2009.
- F. Li, Q. Huang, J. Chen et al., “Apoptotic cells activate the “phoenix rising” pathway to promote wound healing and tissue regeneration,” Science Signaling, vol. 3, no. 110, p. ra13, 2010.
- C. Bonner, S. Bacon, C. G. Concannon et al., “INS-1 cells undergoing caspase-dependent apoptosis enhance the regenerative capacity of neighboring cells,” Diabetes, vol. 59, no. 11, pp. 2799–2808, 2010.
- I. Kuhrer, R. Kuzmits, W. Linkesch, and H. Ludwig, “Topical PGE2 enhances healing of chemotherapy-associated mucosal lesions,” The Lancet, vol. 1, no. 8481, p. 623, 1986.
- V. M. Paralkar, F. Borovecki, H. Z. Ke et al., “An EP2 receptor-selective prostaglandin E2 agonist induces bone healing,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 11, pp. 6736–6740, 2003.
- G. I. Atsumi, M. Tajima, A. Hadano, Y. Nakatani, M. Murakami, and I. Kudot, “Fas-induced arachidonic acid release is mediated by Ca2+-independent phospholipase A2 but not cytosolic phospholipase A2, which undergoes proteolytic inactivation,” Journal of Biological Chemistry, vol. 273, no. 22, pp. 13870–13877, 1998.
- W. Goessling, T. E. North, S. Loewer et al., “Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration,” Cell, vol. 136, no. 6, pp. 1136–1147, 2009.
- J. Reader, D. Holt, and A. Fulton, “Prostaglandin E2 EP receptors as therapeutic targets in breast cancer,” Cancer and Metastasis Reviews, vol. 30, no. 3-4, pp. 449–463, 2011.
- R. T. Moon, A. D. Kohn, G. V. De Ferrari, and A. Kaykas, “WNT and β-catenin signalling: diseases and therapies,” Nature Reviews Genetics, vol. 5, no. 9, pp. 691–701, 2004.
- M. D. Castellone, H. Teramoto, B. O. Williams, K. M. Druey, and J. S. Gutkind, “Medicine: prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-β-catenin signaling axis,” Science, vol. 310, no. 5753, pp. 1504–1510, 2005.
- J. E. Rundhaug and S. M. Fischer, “Molecular mechanisms of mouse skin tumor promotion,” Cancers, vol. 2, no. 2, pp. 436–482, 2010.
- Y. M. Sung, G. He, and S. M. Fischer, “Lack of expression of the EP2 but not EP3 receptor for prostaglandin E2 results in suppression of skin tumor development,” Cancer Research, vol. 65, no. 20, pp. 9304–9311, 2005.
- R. L. Keith, M. W. Geraci, S. P. Nana et al., “Prostaglandin E2 receptor subtype 2 (EP2) null mice are protected against murine lung tumorigenesis,” Anticancer Research, vol. 26, no. 4 B, pp. 2857–2861, 2006.
- Y. Sasaki, D. Kamei, Y. Ishikawa et al., “Microsomal prostaglandin E synthase-1 is involved in multiple steps of colon carcinogenesis,” Oncogene, vol. 31, no. 24, pp. 2943–2952, 2012.
- J. F. Kerr, A. H. Wyllie, and A. R. Currie, “Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics,” British Journal of Cancer, vol. 26, no. 4, pp. 239–257, 1972.
- A. H. Wyllie, “Apoptosis: cell death in tissue regulation,” Journal of Pathology, vol. 153, no. 4, pp. 313–316, 1987.
- E. M. Michalak, C. J. Vandenberg, A. R. D. Delbridge et al., “Apoptosis-promoted tumorigenesis: γ-irradiation-induced thymic lymphomagenesis requires Puma-driven leukocyte death,” Genes and Development, vol. 24, no. 15, pp. 1608–1613, 2010.
- V. Labi, M. Erlacher, G. Krumschnabel et al., “Apoptosis of leukocytes triggered by acute DNA damage promotes lymphoma formation,” Genes and Development, vol. 24, no. 15, pp. 1602–1607, 2010.
- K. Nakano and K. H. Vousden, “PUMA, a novel proapoptotic gene, is induced by p53,” Molecular Cell, vol. 7, no. 3, pp. 683–694, 2001.
- K. Cain, S. B. Bratton, and G. M. Cohen, “The Apaf-1 apoptosome: a large caspase-activating complex,” Biochimie, vol. 84, no. 2-3, pp. 203–214, 2002.
- W. Qiu, X. Wang, B. Leibowitz, W. Yang, L. Zhang, and J. Yu, “PUMA-mediated apoptosis drives chemical hepatocarcinogenesis in mice,” Hepatology, vol. 54, no. 4, pp. 1249–1258, 2011.
- S. Maeda, H. Kamata, J. L. Luo, H. Leffert, and M. Karin, “IKKβ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis,” Cell, vol. 121, no. 7, pp. 977–990, 2005.
- T. Sakurai, G. He, A. Matsuzawa et al., “Hepatocyte necrosis induced by oxidative stress and IL-1α release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis,” Cancer Cell, vol. 14, no. 2, pp. 156–165, 2008.
- G. M. Ledda-Columbano, O. Coni, M. Curto et al., “Mitogen-induced liver hyperplasia does not substitute for compensatory regeneration during promotion of chemical hepatocarcinogenesis,” Carcinogenesis, vol. 13, no. 3, pp. 379–383, 1992.
- Q. Huang, F. Li, X. Liu et al., “Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy,” Nature Medicine, vol. 17, no. 7, pp. 860–866, 2011.
- R. W. Johnstone, A. A. Ruefli, and S. W. Lowe, “Apoptosis: a link between cancer genetics and chemotherapy,” Cell, vol. 108, no. 2, pp. 153–164, 2002.
- T. Tenev, K. Bianchi, M. Darding et al., “The ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs,” Molecular Cell, vol. 43, no. 3, pp. 432–448, 2011.
- C. J. F. Van Noorden, “Editorial: the history of Z-VAD-FMK, a tool for understanding the significance of caspase inhibition,” Acta Histochemica, vol. 103, no. 3, pp. 241–251, 2001.
- D. Chauvier, S. Renolleau, S. Holifanjaniaina et al., “Targeting neonatal ischemic brain injury with a pentapeptide-based irreversible caspase inhibitor,” Cell Death and Disease, vol. 2, no. 9, p. e203, 2011.
- P. Vandenabeele, T. Vanden Berghe, and N. Festjens, “Caspase inhibitors promote alternative cell death pathways,” Science's STKE, vol. 2006, no. 358, p. pe44, 2006.
- D. Ditsworth, W. X. Zong, and C. B. Thompson, “Activation of poly(ADP)-ribose polymerase (PARP-1) induces release of the pro-inflammatory mediator HMGB1 from the nucleus,” Journal of Biological Chemistry, vol. 282, no. 24, pp. 17845–17854, 2007.
- J. Campisi and F. D'Adda Di Fagagna, “Cellular senescence: when bad things happen to good cells,” Nature Reviews Molecular Cell Biology, vol. 8, no. 9, pp. 729–740, 2007.
- A. G. Dalgleish and K. O'Byrne, “Inflammation and cancer: the role of the immune response and angiogenesis,” Cancer Treatment and Research, vol. 130, pp. 1–38, 2006.
- T. Kuilman, C. Michaloglou, L. C. W. Vredeveld et al., “Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network,” Cell, vol. 133, no. 6, pp. 1019–1031, 2008.
- V. G. Gorgoulis and T. D. Halazonetis, “Oncogene-induced senescence: the bright and dark side of the response,” Current Opinion in Cell Biology, vol. 22, no. 6, pp. 816–827, 2010.
- H. D. Ryoo, T. Gorenc, and H. Steller, “Apoptotic cells can induce compensatory cell proliferation through the JNK and the wingless signaling pathways,” Developmental Cell, vol. 7, no. 4, pp. 491–501, 2004.
- J. R. Huh, M. Guo, and B. A. Hay, “Compensatory proliferation induced by cell death in the Drosophila wing disc requires activity of the apical cell death caspase dronc in a nonapoptotic role,” Current Biology, vol. 14, no. 14, pp. 1262–1266, 2004.
- B. S. Wells, E. Yoshida, and L. A. Johnston, “Compensatory proliferation in Drosophila imaginal discs requires dronc-dependent p53 activity,” Current Biology, vol. 16, no. 16, pp. 1606–1615, 2006.
- S. Kondo, N. Senoo-Matsuda, Y. Hiromi, and M. Miura, “DRONC coordinates cell death and compensatory proliferation,” Molecular and Cellular Biology, vol. 26, no. 19, pp. 7258–7268, 2006.
- A. Pérez-Garijo, F. A. Martín, and G. Morata, “Caspase inhibition during apoptosis causes abnormal signalling and developmental aberrations in Drosophila,” Development, vol. 131, no. 22, pp. 5591–5598, 2004.
- C. M. Ulrich, J. Bigler, and J. D. Potter, “Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics,” Nature Reviews Cancer, vol. 6, no. 2, pp. 130–140, 2006.
- A. Albini and M. B. Sporn, “The tumour microenvironment as a target for chemoprevention,” Nature Reviews Cancer, vol. 7, no. 2, pp. 139–147, 2007.
- M. R. Elliott, F. B. Chekeni, P. C. Trampont et al., “Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance,” Nature, vol. 461, no. 7261, pp. 282–286, 2009.
- F. B. Chekeni, M. R. Elliott, J. K. Sandilos et al., “Pannexin 1 channels mediate 'find-me' signal release and membrane permeability during apoptosis,” Nature, vol. 467, no. 7317, pp. 863–867, 2010.
- K. Lauber, E. Bohn, S. M. Kröber et al., “Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal,” Cell, vol. 113, no. 6, pp. 717–730, 2003.
- D. R. Gude, S. E. Alvarez, S. W. Paugh et al., “Apoptosis induces expression of sphingosine kinase 1 to release sphingosine-1-phosphate as a “come-and-get-me” signal,” FASEB Journal, vol. 22, no. 8, pp. 2629–2638, 2008.
- K. Ravichandran, “Beginnings of a good apoptotic meal: the find-me and eat-me signaling pathways,” Immunity, vol. 35, no. 4, pp. 445–455, 2011.
- A. B. Roberts and L. M. Wakefield, “The two faces of transforming growth factor β in carcinogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 15, pp. 8621–8623, 2003.
- L. Barron and T. A. Wynn, “Fibrosis is regulated by Th2 and Th17 responses and by dynamic interactions between fibroblasts and macrophages,” American Journal of Physiology, vol. 300, no. 5, pp. G723–G728, 2011.
- C. Steidl, T. Lee, S. P. Shah et al., “Tumor-associated macrophages and survival in classic Hodgkin's lymphoma,” New England Journal of Medicine, vol. 362, no. 10, pp. 875–885, 2010.
- B. Z. Qian, J. Li, H. Zhang et al., “CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis,” Nature, vol. 475, no. 7355, pp. 222–225, 2011.